Advertisement

HCV-Associated Membranoproliferative Glomerulonephritis

  • Christos P. Argyropoulos
  • Sheldon Bastacky
  • John Prentiss Johnson
Chapter

Abstract

Hepatitis C virus (HCV) is a blood-borne and sexually transmitted single-stranded RNA flavivirus that causes a broad spectrum of liver disease, ranging from acute to chronic hepatitis, cirrhosis, and hepatocellular carcinoma. The worldwide prevalence of HCV positivity is highly variable. Hepatitis C infection is associated with a wide variety of renal diseases but the most common pattern of renal injury is Membranoproliferative glomerulonephritis (>50% of cases). This chapter reviews the epidemiology, pathogenesis, clinical and laboratory manifestations, pathology, and differential diagnosis of HCV-associated cryoglobulinemic. Therapeutic approaches to the management of patients with nephritic, nephritic, and vasculitic manifestations are also briefly considered.

Keywords

Glomerular Basement Membrane Mixed Cryoglobulinemia Membranoproliferative Glomerulonephritis Glomerular Capillary Wall Mesangial Matrix Expansion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Shepard CW, Finelli L, Alter MJ (2005) Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5(9):558–567PubMedCrossRefGoogle Scholar
  2. 2.
    Lapinski TW, Parfieniuk A, Rogalska-Plonska M et al (2009) Prevalence of cryoglobulinaemia in hepatitis C virus- and hepatitis C virus/human immunodeficiency virus-infected individuals: implications for renal function. Liver Int 29(8):1158–1161PubMedCrossRefGoogle Scholar
  3. 3.
    Meyers CM, Seeff LB, Stehman-Breen CO, Hoofnagle JH (2003) Hepatitis C and renal disease: an update. Am J Kidney Dis 42(4):631–657PubMedCrossRefGoogle Scholar
  4. 4.
    Yamabe H, Johnson RJ, Gretch DR et al (1995) Hepatitis C virus infection and membranoproliferative glomerulonephritis in Japan. J Am Soc Nephrol 6(2):220–223PubMedGoogle Scholar
  5. 5.
    Kayali Z, Buckwold VE, Zimmerman B, Schmidt WN (2002) Hepatitis C, cryoglobulinemia, and cirrhosis: a meta-analysis. Hepatology 36(4 Pt 1):978–985PubMedGoogle Scholar
  6. 6.
    Giordano TP, Henderson L, Landgren O et al (2007) Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA 297(18):2010–2017PubMedCrossRefGoogle Scholar
  7. 7.
    Ferri C, Sebastiani M, Giuggioli D et al (2004) Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum 33(6):355–374PubMedCrossRefGoogle Scholar
  8. 8.
    Horcajada JP, García-Bengoechea M, Cilla G et al (1999) Mixed cryoglobulinaemia in patients with chronic hepatitis C infection: prevalence, significance and relationship with different viral genotypes. Ann Med 31(5):352–358PubMedCrossRefGoogle Scholar
  9. 9.
    Dammacco F, Sansonno D (1992) Antibodies to hepatitis C virus in essential mixed cryoglobulinaemia. Clin Exp Immunol 87(3):352–356PubMedCrossRefGoogle Scholar
  10. 10.
    Ferri C, Greco F, Longombardo G et al (1991) Association between hepatitis C virus and mixed cryoglobulinemia [see comment]. Clin Exp Rheumatol 9(6):621–624PubMedGoogle Scholar
  11. 11.
    Disdier P, Harlé JR, Weiller PJ (1991) Cryoglobulinaemia and hepatitis C infection. Lancet 338(8775):1151–1152PubMedCrossRefGoogle Scholar
  12. 12.
    Ferri C, Greco F, Longombardo G et al (1991) Hepatitis C virus antibodies in mixed cryoglobulinemia. Clin Exp Rheumatol 9(1):95–96PubMedGoogle Scholar
  13. 13.
    Kamar N, Izopet J, Alric L et al (2008) Hepatitis C virus-related kidney disease: an overview. Clin Nephrol 69(3):149–160PubMedGoogle Scholar
  14. 14.
    Roccatello D, Fornasieri A, Giachino O et al (2007) Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis. Am J Kidney Dis 49(1):69–82PubMedCrossRefGoogle Scholar
  15. 15.
    Cacoub P, Renou C, Kerr G et al (2001) Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia. Arthritis Rheum 44(9):2118–2124PubMedCrossRefGoogle Scholar
  16. 16.
    Renou C, Halfon P, Pol S et al (2002) Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levels. Gut 51(4):585–590PubMedCrossRefGoogle Scholar
  17. 17.
    Ferri C (2008) Mixed cryoglobulinemia. Orphanet J Rare Dis 3:25PubMedCrossRefGoogle Scholar
  18. 18.
    Dal Maso L, Franceschi S (2006) Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies. Cancer Epidemiol Biomarkers Prev 15(11):2078–2085PubMedCrossRefGoogle Scholar
  19. 19.
    Rostagno AA, Gallo G, Gold LI (2002) Binding of polymeric IgG to fibronectin in extracellular matrices: an in vitro paradigm for immune-complex deposition. Mol Immunol 38(15):1101–1111PubMedCrossRefGoogle Scholar
  20. 20.
    Fornasieri A, Armelloni S, Bernasconi P et al (1996) High binding of immunoglobulin M kappa rheumatoid factor from type II cryoglobulins to cellular fibronectin: a mechanism for induction of in situ immune complex glomerulonephritis? Am J Kidney Dis 27(4):476–483PubMedCrossRefGoogle Scholar
  21. 21.
    Rodríguez-Iñigo E, Casqueiro M, Bartolomé J et al (2000) Hepatitis C virus RNA in kidney biopsies from infected patients with renal diseases. J Viral Hepat 7(1):23–29PubMedCrossRefGoogle Scholar
  22. 22.
    Sansonno D, Gesualdo L, Manno C et al (1997) Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobulinemic membranoproliferative glomerulonephritis. Hepatology 25(5):1237–1244PubMedCrossRefGoogle Scholar
  23. 23.
    Sabry AA, Sobh MA, Irving WL et al (2002) A comprehensive study of the association between hepatitis C virus and glomerulopathy. Nephrol Dial Transplant 17(2):239–245PubMedCrossRefGoogle Scholar
  24. 24.
    Wornle M, Schmid H, Banas B et al (2006) Novel role of toll-like receptor 3 in hepatitis C-associated glomerulonephritis. Am J Pathol 168(2):370–385PubMedCrossRefGoogle Scholar
  25. 25.
    Alpers CE, Kowalewska J (2007) Emerging paradigms in the renal pathology of viral diseases. Clin J Am Soc Nephrol 2(Suppl 1):S6–S12PubMedCrossRefGoogle Scholar
  26. 26.
    Tarantino A, Campise M, Banfi G et al (1995) Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis. Kidney Int 47(2):618–623PubMedCrossRefGoogle Scholar
  27. 27.
    D’Amico G (1998) Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. Kidney Int 54(2):650–671PubMedCrossRefGoogle Scholar
  28. 28.
    Davda R, Peterson J, Weiner R, Croker B, Lau JY (1993) Membranous glomerulonephritis in association with hepatitis C virus infection. Am J Kidney Dis 22(3):452–455PubMedGoogle Scholar
  29. 29.
    Stehman-Breen C, Alpers CE, Fleet WP, Johnson RJ (1999) Focal segmental glomerular sclerosis among patients infected with hepatitis C virus. Nephron 81(1):37–40PubMedCrossRefGoogle Scholar
  30. 30.
    Pouria S, Feehally J (1999) Glomerular IgA deposition in liver disease. Nephrol Dial Transplant 14(10):2279–2282PubMedCrossRefGoogle Scholar
  31. 31.
    Markowitz GS, Cheng JT, Colvin RB et al (1998) Hepatitis C viral infection is associated with fibrillary ­glomerulonephritis and immunotactoid glomerulopathy. J Am Soc Nephrol 9(12):2244–2252PubMedGoogle Scholar
  32. 32.
    Peter H, Savage C (2003) Idiopathic membranoproliferative glomerulonephritis. In: Therapy in nephrology and hypertension. Saunders, Philadelphia, pp 247–252Google Scholar
  33. 33.
    Fabrizi F, Lunghi G, Messa P, Martin P (2008) Therapy of hepatitis C virus-associated glomerulonephritis: current approaches. J Nephrol 21(6):813–825PubMedGoogle Scholar
  34. 34.
    Perico N, Cattaneo D, Bikbov B, Remuzzi G (2009) Hepatitis C infection and chronic renal diseases. Clin J Am Soc Nephrol 4(1):207–220PubMedCrossRefGoogle Scholar
  35. 35.
    Johnson RJ, Gretch DR, Couser WG et al (1994) Hepatitis C virus-associated glomerulonephritis. Effect of alpha-interferon therapy. Kidney Int 46(6):1700–1704PubMedCrossRefGoogle Scholar
  36. 36.
    Alric L, Plaisier E, Thébault S et al (2004) Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN. Am J Kidney Dis 43(4):617–623PubMedCrossRefGoogle Scholar
  37. 37.
    McHutchison JG, Gordon SC, Schiff ER et al (1998) Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 339(21):1485–1492PubMedCrossRefGoogle Scholar
  38. 38.
    Bruchfeld A, Lindahl K, Schvarcz R, Ståhle L (2002) Dosage of ribavirin in patients with hepatitis C should be based on renal function: a population pharmacokinetic analysis. Ther Drug Monit 24(6):701–708PubMedCrossRefGoogle Scholar
  39. 39.
    Bruchfeld A, Lindahl K, Reichard O (2006) Pegylated interferon and ribavirin treatment for hepatitis C in haemodialysis patients. J Viral Hepat 13(5):316–321PubMedCrossRefGoogle Scholar
  40. 40.
    Beddhu S, Bastacky S, Johnson JP (2002) The clinical and morphologic spectrum of renal cryoglobulinemia. Medicine (Baltimore) 81(5):398–409CrossRefGoogle Scholar
  41. 41.
    Saadoun D, Resche-Rigon M, Sene D et al (2008) Rituximab combined with Peg-interferon-ribavirin in refractory hepatitis C virus-associated cryoglobulinaemia vasculitis. Ann Rheum Dis 67(10):1431–1436PubMedCrossRefGoogle Scholar
  42. 42.
    Saadoun D, Resche Rigon M, Sene D et al (2010) Rituximab plus Peg-Interferon {alpha}/ribavirin compared to Peg-interferon {alpha}/ribavirin in hepatitis C related mixed cryoglobulinemia. Blood 116(3):326–334, 2010 May 3 [cited 2010 May 28]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20439619 PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2012

Authors and Affiliations

  • Christos P. Argyropoulos
    • 1
  • Sheldon Bastacky
    • 2
  • John Prentiss Johnson
    • 1
  1. 1.Renal and Electrolyte Division, Department of Internal MedicineUniversity of PittsburghPittsburghUSA
  2. 2.Department of PathologyUniversity of PittsburghPittsburghUSA

Personalised recommendations